ABR-E

NYSE Arbor Realty Trust 6.25% Series E Cumulative Redeemable Preferred Stock
Oct 3, 2026 · 12:08 AM ET EOD Market Closed

$13.19 ↑ +0.00 (+0.00%) Trading Up from the previous close of $13.19, $0.21 below the day’s high of $13.40

YTD change
-21.86%
vs 20-day SMA
-11.75%
vs 200-day SMA
-19.93%

Price ranges

Previous day
$13.30 $13.61
open $13.50 close $13.40
-$0.10 (-0.74%)
Today
$13.12 $13.40
open $13.35 now $13.19
-$0.16 (-1.20%)
Past week
$13.23 $15.01
from $15.01 now $13.19
-$1.82 (-12.13%)
Past month
$13.23 $15.50
from $15.49 now $13.19
-$2.30 (-14.86%)
This year
$13.12 $17.90
from $16.88 now $13.19
-$3.69 (-21.86%)

Price & Performance

-3.60 (-21.44%) / 6M

$12.86$14.45$16.05$17.64Apr 2Jul 6Oct 2

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 48.7% away from all-time highs of $25.69
  • ABR-E is down 22% since the beginning of the year
  • ABR-E is down 29% over the past 12 months
  • ABR-E is down 15% over the past 1 month

ABR-E reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -29.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-75
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A

Balance sheet & scale

IncomeN/A
RevenueN/A
CashN/A
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE
Sector Finance and Insurance
Sub Sector Credit Intermediation and Related Activities
Market cap N/A

Competitor comparison

TickerCompany PriceChange
PXT.CAT PAREX RES INC $26.93 +0.41%
TRIN Trinity Capital, Inc. $17.59 +0.23%
ABR Arbor Realty Trust Inc $3.56 -4.04%
AI.CAT ATRIUM MTG INVT CORP $11.26 +0.09%
AMIVF Atrium Mortgage Investment Corp. $7.90 -0.13%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.